Wonderful news, but I always get an “I Am Legend” dread when I read these stories.
IIRC from another article, this is a monoclonal antibody drug, correct?
12 The patients all had a very specific sub-type of cancer that was susceptible to this treatment. The sub-type makes up 5%-10% of all rectal cancers.
Made from fully humanized mice. Gross
Probably therefore linked to abortion
This is the kind of thing that inspires young people to go intro the sciences and research. I say, my hats off to the researchers! Congratulations, and I hope they continue to find ways to get rid of cancer. For real, instead of just putting a bandaid on it.
Pharmas aren’t to be trusted anymore. Other info on Glaxo Smith Kline’s product imply the ‘leveraging’ of human genetics and immune system - which sounds just like the needless, toxic Covid ‘vaccines’, so I suspect this is related technology but they know to hide the details from us. Just my 2.
Taking bets on when this drug will be approved and released by the FDA:
1. 20 years
2. 10 years
3. Never
The last thing they want is a cure for cancer or heart disease. There is too much money to be made from lifelong treatments. Once you’re cured, you don’t need them.
Immunotherapy is the key to successful cancer treatment. Monoclonal antibodies are just one approach. Tumor vaccines directed at the foreign antigens that tumor cells feature are necessary. The problem is that tumor cells have afferent and efferent features that protect them from a host’s own immune system. They produce cytokines that stall phagocytosis of tumor cells by the dendritic cells. Processing of tumor antigen by the dendritic cells are key to triggering the T cell mediated delayed response that features CD4 lymphocytes and killer T cells. Without phagocytosis by the dendritic cells the immune charge never happens. Also the tumors feature surface proteins that protect them from any T lymphocytes that might get directed against them. The key is to disrupt these afferent and efferent tumor defense capabilities. One approach may be to first freeze a resected tumor to kill it, then slice it into thin slices and let it soak in saline. the remaining cytokines will then diffuse away. Then take the slices and soak it in a urushiol oil bath. Urushiol is the oil in poison ivy that causes a severe rash which is a classic delayed T cell firestorm. The urushiol will bind to the tumor antigens. Then the tumor slices in the urushiol bath would be macerated. This would be your cutaneous tumor vaccine. It would then be applied to an area of the skin. The dendrites of the skin, the Langerhans cells, would then hopefully phagocytize the urushiol/tumor antigen compounds and start an anti tumor immune response that would attack viable tumors elsewhere in the body. Of course this does not address the efferent tumor defense mechanisms such as the tumors defensive surface proteins However its been long noted that tumor cells avidly concentrate potassium and have a much higher intracellular level of potassium than normal cells. They maintain this gradient by use of the so called ATPase pump. This pump is weakened by digoxin. Concurrent digitalization of the patient when applying the vaccine may be useful.
This is only a theory and has never been tested. However if cancer is to be stopped, IMHO it will due to the successful development of some sort of tumor vaccines. Cancers are a failure of the host’s immune system.
.
I was just reading about this: https://www.marca.com/en/lifestyle/us-news/2022/06/09/62a131e8e2704ef16e8b45df.html#
Huge if true.